Basecamp Wealth Advisors’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$263K Buy
679
+1
+0.1% +$371 0.05% 215
2026
Q1
$198K Sell
678
-19
-3% -$6.25K 0.04% 264
2025
Q4
$244K Buy
+697
New +$236K 0.05% 200

Other funds holding ELV

Basecamp Wealth Advisors's ELV Position: Q2 2026 in Review

Basecamp Wealth Advisors increased its Elevance Health (ELV) stake by 0.15% in Q2 2026, buying an estimated $371 and bringing the position to 679 shares worth $263K. The position accounts for 0.05% of the portfolio, ranked #215.

Basecamp Wealth Advisors first reported a position in ELV in Q4 2025 and has held it in 3 quarters since. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Basecamp Wealth Advisors held 679 shares of Elevance Health worth $263K as of Q2 2026.
  • Basecamp Wealth Advisors bought 1 Elevance Health share in Q2 2026, an estimated $371.
  • Elevance Health made up 0.05% of Basecamp Wealth Advisors's portfolio in Q2 2026, its #215 holding.
  • Basecamp Wealth Advisors first reported a position in Elevance Health in Q4 2025 and has held it in 3 quarters since.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Basecamp Wealth Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.